The nuclear retinoic acid (RA) receptors (RARa, b and c) are ligand-dependent regulators of transcription. Upon activation by RA, they are recruited at the promoters of target genes together with several coregulators. Then, they are degraded by the ubiquitin proteasome system. Here, we report that the degradation of the RARa subtype involves ubiquitination and the tripartite motif protein TRIM24, which was originally identified as a ligand-dependent corepressor of RARa. We show that in response to RA, TRIM24 serves as an adapter linking RARa to the proteasome for its degradation. In addition, TRIM24 and the proteasome are recruited with RARa to the promoters of target genes and thus are inherently linked to RARa transcriptional activity.
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Keywords: degradation; proteasome; retinoic acid receptor; transcription; TRIM24; ubiquitin Nuclear receptors are ligand-dependent regulators of transcription and regulate the expression of a battery of target genes via binding response elements located in genes promoters and coordinating the formation of a large transcription initiation complex including coactivators, histone modifying enzymes, general transcription factors and RNA polymerase II. NRs transcriptional activity is modulated through a fine-tuned code of post-translational modifications such as phosphorylation, acetylation, sumoylation and ubiquitination [1] [2] [3] . Increasing evidence indicates the importance of ubiquitination in the regulation of NRs activity and stability [4] [5] [6] [7] .
Ubiquitination involves the ubiquitin-activating enzyme E1, a ubiquitin-conjugating enzyme E2 and finally a ubiquitin ligase E3 that mediates the transfer of ubiquitin from E2 to the substrate [8, 9] . The major function of ubiquitination is to signal protein degradation by the 26S proteasome which comprises a cylindrical 20S chamber where proteolysis occurs and a 19S regulatory complex which recognises the ubiquitinated proteins and governs their entry into the 20S catalytic chamber [10, 11] . The degradation of ubiquitinated protein substrates includes several steps that are critically coordinated [12] : recognition of the substrate by Abbreviations DUB, deubiquitinating enzyme; MEFs, mouse embryonic fibroblasts; PIC, protease inhibitor cocktail; RA, retinoic acid; RAR, retinoic acid receptor; RING, really interesting new gene; UPS, ubiquitin proteasome system. subunits of the 19S with high ubiquitin affinity and with ATPase activity [10, 13, 14] , unfolding, translocation through the opened gate of the 20S and deubiquitination by 19S-associated deubiquitinating enzymes (DUBs) [15] [16] [17] [18] . The current idea is that proteasomal degradation of NRs would provide an efficient way to limit NRs functions and/or to facilitate multiple rounds of transcription initiation [4, 6] .
Among the large family of nuclear receptors, retinoic acid receptors (RARa, b and c) are degraded by the ubiquitin proteasome system (UPS) after addition of the ligand, retinoic acid (RA) [19, 20] . However, the underlying mechanism of RARs ubiquitination/degradation is still unclear. Here, we show that the tripartite motif protein TRIM24 is involved in the RA-induced degradation of the RARa subtype. TRIM24 was originally identified as transcriptional intermediary factor 1a, and as a ligand-dependent corepressor of RARa [21, 22] 
Materials and methods

Plasmids, antibodies and reagents
The pSG5-based expression vector for human RARa was previously described [27] . Rabbit polyclonal antibodies against RARa [RPa(F)] were purified on sulfolink gel columns (Pierce Chemical, Rockford, IL, USA) coupled to the corresponding immunising peptide [28, 29] . The mouse monoclonal anti RARa antibodies, Ab9a (F) and Ab10a (A1) [27] , raised in house were purified and concentrated from ascitic fluid on protein G sepharose [30] . Mouse monoclonal antibodies against SUG1 were previously described [19] . Mouse monoclonal antibodies against TRIM24 (Ab5T1E8) [31] were purified from ascitic fluid on protein G sepharose. Polyclonal antibodies against RARa (ChIP grade) and the 20S Proteasome b5 subunit (PSMB5; C-19) were from Santa Cruz Biotechnology INC. Europe (Heidelberg, Germany). Mouse monoclonal antibodies against ubiquitin were from Enzo Life Sciences (ELS) AG (Villeurbanne, France). Those against GAPDH were from MERCK Millipore (Dachstein, France). ON-TARGETplus human RARa (L-003437-00) and nontargeting (D-001210-01-05) siRNA SMART pools were from Thermofisher Scientific (Illkirch, France).
All-trans-RA was purchased from Sigma-Aldrich (MERCK Millipore). MG132 was from Bio-Techne-R&D Systems Europe (Lille, France). PYR-41 was from VWR International SAS (Fontenay sous Bois, France) and DUB inhibitor VI from MERCK Millipore. Complete protease inhibitor cocktail (PIC) and PhosSTOP were from Roche Diagnostics (Meylan, France).
Cell lines, extracts preparation and immunoblotting
MCF7 cells, HeLa cells and mouse embryonic fibroblasts (MEFs) were cultured according to standard procedures. TRIM24À/À MEFs were described in Khetchounian et al.
[21]. MCF7 cells were transfected using the X-tremeGENE HP DNA Transfection Reagent (Roche Diagnostics) according to the manufacturer's protocol. When 80-90% confluent, cells were treated with all-trans RA or vehicle (0.1% ethanol), after 24 h in low (1%) serum medium conditions, without insulin and phenol red.
Cells were harvested and whole cell extracts were prepared in lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5% glycerol and 0.5% Igepal CA-630). All buffers were ice-cold and supplemented with 1 mM PMSF, 50 lM NaF, PIC and PhosSTOP. The extracts were proceeded for immunoblotting as previously described [32] .
Immunoprecipitation
Immunoprecipitation was performed with mouse monoclonal antibodies immobilised on Dynabeads Protein G (Invitrogen, Thermofischer Scientific). After washing, the immunoprecipitated proteins were eluted with SDS-sample loading buffer, boiled, subjected to SDS/PAGE and analysed by immunoblotting. 
Purification of ubiquitinated proteins
Proteasome isolation
Proteasome isolation was performed with the Proteasome Isolation Kit (Calbiochem 
RNA isolation and quantitative RT-PCR
Total RNA was isolated using the Sigma RNA extraction kit and subjected for qRT-PCR (QuantiTect SYBR Green RTPCR; Qiagen). The primers sequences are available upon request. mRNA expression was normalised with the house-keeping gene, GAPDH.
ChIP
Cells were cross-linked with 1% formaldehyde at room temperature, scrapped, lyzed and sonicated at 4°C using a Bioruptor (Diagenode, Liege, Belgium). Samples were immunoprecipitated with antibodies at 4°C overnight and Dynabeads Protein A or Protein G were added and incubated at 4°C for 4 h. After washing, the complexes were eluted and the cross-linking was heat-reversed. DNA fragments were purified using QIA quick PCR putification kit (QIAGEN) and analysed by qPCR using sets of primers that are available upon request. Occupancy of the promoters was calculated by normalising the PCR signals from the immunoprecipitated samples to the signals obtained from the input DNA.
Results and Discussion
RARa is degraded by the ubiquitin proteasome system after RA addition
The nuclear RA receptor RARa was rapidly (within 2 h) degraded after RA addition to several cell lines such as MEFs, human breast cancer cells (MCF7 cell line) and human cervix cancer cells (HeLa cell line; Fig. 1A , lanes 5-8). The proteasome inhibitor MG132 prevented RARa degradation, confirming that proteasome mediates the degradation of the receptor (Fig. 1B) .
Then we investigated whether RARa is ubiquitinated and whether ubiquitination regulates the degradation of RARa by the proteasome. MEFs were treated with RA in the absence or presence of MG132 for different times (before degradation occurs), followed by enrichment of the ubiquitinated proteins in an ubicapture assay and immunoblotting analysis of RARa in the eluates. The assay showed that RARa is ubiquitinated (Fig. 1C) . Moreover, the ubiquitinated forms of RARa increased after RA addition either in the absence (Fig. 1C, lanes 1-3) or in the presence of MG132 (Fig. 1C, lanes 4-6) . Quantification of ubiquitinated RARa is shown in Fig. 1D .
Interestingly, pretreatment of the cells with PYR-41, a small molecule chemical inhibitor of ubiquitin-activating enzymes E1, abrogated the degradation of RARa observed after RA addition (Fig. 1E) . Reciprocally, ubiquitin protease inhibitors such as DUB inhibitor VI accelerated the degradation of RARa (Fig. 1F) . Collectively, these results indicate that ubiquitination regulates RARa proteasomal degradation after RA addition.
TRIM 24 is involved in the degradation of RARa by the ubiquitin proteasome system
Recently, TRIM24, a nonconventional coregulator that binds liganded RARs [22, 33] , was found to be an E3 ubiquitin ligase [25, 34] . Therefore, we investigated whether TRIM24 is involved in the ubiquitination and/or degradation of RARa.
First, we corroborated that TRIM24 does interact with RARa in MEFs in coimmunoprecipitation experiments ( Fig. 2A) . Interestingly, in MEFs invalidated for TRIM24 (TRIM24À/À MEFs) [21], RARa was not degraded after RA addition (Fig. 2B, lanes 5-8) , indicating that TRIM24 plays a role in the degradation of RARa.
Then, we analysed whether TRIM24 regulates the ubiquitination of RARa, a process necessary for recognition by the proteasome. With that aim, WT and TRIM24À/À MEFs treated or not with RA and MG132 were compared in an UbiCapture assay. As expected, the ubiquitinated forms of RARa accumulated in WT MEFs treated with RA and MG132 (Fig. 2C, lane 3) . However, in TRIM24À/À MEFs, the accumulation of the ubiquitinated forms of RARa observed after RA addition was not suppressed, indicating that TRIM24 is not involved in the ubiquitination of RARa. In fact, we observed a marked increase in the ubiquitination of RARa (Fig. 2C , compare lane 6 to lane 3), suggesting that TRIM24 would rather mediate the recognition of RARa by the proteasome.
Next, we investigated whether TRIM24 regulates the interaction of RARa with the proteasome. WT and TRIM24À/À MEFs were treated with RA for 90 min and the extracts were pull down with proteasome binding beads (GST-Ubl). The eluates were analysed by immunoblotting for the presence of RARa, TRIM24 and proteasome subunits. The Rpt6/SUG1 subunit of the 19S regulatory sub complex [11] was detected, confirming the efficiency of the assay (Fig. 2D, lanes 6-9) . In the eluates from WT MEFs treated with RA (Fig. 2D, lane 7) a ladder of ubiquitinated forms of RARa was detected as well as TRIM24. In contrast, in the eluates from TRIM24À/À cells, RARa was not detected (Fig. 2D, lanes 8-9) . Collectively, these results indicate that TRIM24 medoates the interaction of ubiquitinated RARa with the proteasome.
TRIM24 controls the recruitment of the proteasome to target promoters
A number of studies demonstrated that the proteasomal degradation of nuclear receptors including RARs requires their engagement in transcription [6, 19] . Therefore, we analysed whether TRIM24 and the proteasome are recruited with RARa at the promoter of endogenous target genes upon RA addition in ChIPqPCR experiments (ChIP followed by quantitative PCR).
In MEFs and MCF7 cells, RA increases the mRNA synthesis of several genes exemplified by the Cyp26a1 gene [28, 35, 36] , with a peak at 2-3 h (Figs 3 and 4 , panels A). In both cell lines, RA induced the rapid recruitment of RARa at the well characterised RA response elements R1 and R2 of the Cyp26a1 gene ( Figs 3C,D and 4B,C) . RARa accumulation peaked at 1-2 h after RA addition and returned to basal values at 3 h, when degraded (see Fig. 1A ). TRIM24 also accumulated at the same R1 and R2 elements, concomitantly with RARa ( Figs 3E,F and 4B,C) . No TRIM24 was recruited in RARa silenced cells (Fig. 3  panels B,E,F) confirming that the recruitment of this coregulator is mediated by RARa. Note that these concomitant recruitments paralleled the Cyp26a1 mRNA synthesis (Figs 3A and 4A) . Neither RARa nor TRIM24 were recruited at the promoter of genes lacking RAREs exemplified by the 36B4 gene (Fig. S1) .
Then, additional ChIP assays revealed that the b5 catalytic subunit (PSMB5) of the 20S proteolytic barrel was also recruited at the R1 and R2 elements of Cyp26a1 in MCF7 cells (Fig. 3G,H ) and in WT MEFs (Fig. 4D,E ), in line with other reports [5, 37] . Remarkably, PSMB5 was not recruited in TRIM24À/ÀMEFs (Fig. 4D,E) , corroborating that TRIM24 regulates the recruitment of the proteasome. These results also indicates that both TRIM24 and the proteasome target RARa for its degradation when DNA-bound and engaged in transcription. Note that in TRIM24À/À MEFs, the Cyp26a1 mRNA synthesis was markedly increased compared to WT MEFs in line with the accumulation of RARa (Fig. 4A) . Collectively, these results corroborate that the degradation of RARa by TRIM24 and the UPS regulates the transcription of RARa-target genes [6, 19] .
Conclusion
The results presented here reveal a novel and unexpected face of the regulation of RARa proteasomal degradation and transcriptional activity, involving the In all panels, data points show mean AE SD of triplicates from two to three individual experiments.
tripartite protein TRIM24. Initially, TRIM24 was known as a ligand-dependent coregulator of nuclear receptors [22, 33, 38] and as an 'attenuator' of an oncogenic function of RARa in hepatocytes [21] . The novelty of this study is that TRIM24 regulates the RAinduced proteasomal degradation of RARa as an adapter linking RARa to the proteasome. The other novelty is that TRIM24 and the proteasome are rapidly and transiently recruited with RARa to RA response elements located in the promoters of RARa target genes and thus mediate the degradation of RARa engaged in transcription. In conclusion, this study demonstrates that TRIM24 and the proteasome are an intrinsic feature of RARa transcriptional activity. 
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